164 related articles for article (PubMed ID: 32801758)
1. Methylcrotonoyl-CoA Carboxylase 2 Promotes Proliferation, Migration and Invasion and Inhibits Apoptosis of Prostate Cancer Cells Through Regulating GLUD1-P38 MAPK Signaling Pathway.
He J; Mao Y; Huang W; Li M; Zhang H; Qing Y; Lu S; Xiao H; Li K
Onco Targets Ther; 2020; 13():7317-7327. PubMed ID: 32801758
[TBL] [Abstract][Full Text] [Related]
2. Methylcrotonoyl-CoA carboxylase 2 overexpression predicts an unfavorable prognosis and promotes cell proliferation in breast cancer.
Liu Y; Yuan Z; Song C
Biomark Med; 2019 Apr; 13(6):427-436. PubMed ID: 30895811
[No Abstract] [Full Text] [Related]
3. MCCC2 promotes HCC development by supporting leucine oncogenic function.
Chen YY; Zhang XN; Xu CZ; Zhou DH; Chen J; Liu ZX; Sun Y; Huang W; Qu LS
Cancer Cell Int; 2021 Jan; 21(1):22. PubMed ID: 33407468
[TBL] [Abstract][Full Text] [Related]
4. GLUD1 inhibits hepatocellular carcinoma progression via ROS-mediated p38/JNK MAPK pathway activation and mitochondrial apoptosis.
Zhao Q; Yu M; Li J; Guo Y; Wang Z; Hu K; Xu F; Liu Y; Li L; Wan D; Zhao Y; Shang J; Zhang J
Discov Oncol; 2024 Jan; 15(1):8. PubMed ID: 38216781
[TBL] [Abstract][Full Text] [Related]
5. MCCC2 overexpression predicts poorer prognosis and promotes cell proliferation in colorectal cancer.
Dai W; Feng H; Lee D
Exp Mol Pathol; 2020 Aug; 115():104428. PubMed ID: 32205097
[TBL] [Abstract][Full Text] [Related]
6. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
[TBL] [Abstract][Full Text] [Related]
7. MCCC2 is a novel mediator between mitochondria and telomere and functions as an oncogene in colorectal cancer.
Liu W; Chen S; Xie W; Wang Q; Luo Q; Huang M; Gu M; Lan P; Chen D
Cell Mol Biol Lett; 2023 Oct; 28(1):80. PubMed ID: 37828426
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of PARVA promotes metastasis by modulating integrin-linked kinase activity and regulating MAPK/ERK and MLC2 signaling in prostate cancer.
Huang C; Shen Q; Song G; He S; Zhou L
Transl Androl Urol; 2021 Feb; 10(2):915-928. PubMed ID: 33718092
[TBL] [Abstract][Full Text] [Related]
9. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
Pan MZ; Song YL; Gao F
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466
[TBL] [Abstract][Full Text] [Related]
10. miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1.
Bai P; Li W; Wan Z; Xiao Y; Xiao W; Wang X; Wu Z; Zhang K; Wang Y; Chen B; Xing J; Wang T
Cancer Manag Res; 2020; 12():2719-2729. PubMed ID: 32368149
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of COPS3 inhibits the progress of prostate cancer through reducing phosphorylated p38 MAPK expression and impairs the epithelial-mesenchymal transition process.
Zhu Z; Hong Y; Zhang F; An L; Yang Q; Huang X; Xu Q
Prostate; 2019 Dec; 79(16):1823-1831. PubMed ID: 31509289
[TBL] [Abstract][Full Text] [Related]
12. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506
[TBL] [Abstract][Full Text] [Related]
13. miR-28-3p inhibits prostate cancer cell proliferation, migration and invasion, and promotes apoptosis by targeting ARF6.
Zhang J; Yao Y; Li H; Ye S
Exp Ther Med; 2021 Nov; 22(5):1205. PubMed ID: 34584550
[TBL] [Abstract][Full Text] [Related]
14. [Role of allograft inflammatory factor-1 in regulating the proliferation, migration and apoptosis of colorectal cancer cells].
Ai XL; Yao F; Wang XJ; Duan DB; Li K; Hu ZY; Yin G; Wang M; Wu BY
Nan Fang Yi Ke Da Xue Xue Bao; 2018 May; 38(5):511-519. PubMed ID: 29891445
[TBL] [Abstract][Full Text] [Related]
15. SLC4A4 promotes prostate cancer progression in vivo and in vitro via AKT-mediated signalling pathway.
Liu Z; Wang Q; Zhai G; Ke S; Yu X; Guo J
Cancer Cell Int; 2022 Mar; 22(1):127. PubMed ID: 35305629
[TBL] [Abstract][Full Text] [Related]
16. Sevoflurane Inhibits Proliferation and Invasion of Human Ovarian Cancer Cells by Regulating JNK and p38 MAPK Signaling Pathway.
Kang K; Wang Y
Drug Des Devel Ther; 2019; 13():4451-4460. PubMed ID: 32021086
[TBL] [Abstract][Full Text] [Related]
17. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the expression and association of retinoblastoma binding protein 6 with the JNK signaling pathway in prostate cancers.
Guan WY; Zhao S; Luo YN
Cell Biol Int; 2020 Oct; 44(10):2107-2119. PubMed ID: 32662898
[TBL] [Abstract][Full Text] [Related]
19. Patchouli alcohol inhibits GPBAR1-mediated cell proliferation, apoptosis, migration, and invasion in prostate cancer.
Cai J; Zhao J; Gao P; Xia Y
Transl Androl Urol; 2022 Nov; 11(11):1555-1567. PubMed ID: 36507482
[TBL] [Abstract][Full Text] [Related]
20. SPAG9 promotes prostate cancer proliferation and metastasis via MAPK signaling pathway.
Xiao C; Li M; Huang Q; Si-Tu J
Am J Transl Res; 2019; 11(8):5249-5260. PubMed ID: 31497238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
